← Back to dossier
Patient handout

Ulcerative Colitis

PRODUCTION

1. Your condition

This handout is for ulcerative colitis. Your care team identified this based on: bloody diarrhea ± urgency / tenesmus.

Other reasons your team may use this plan: chronic rectal bleeding / mucous in stool; severe flare with systemic toxicity (truelove-witts); elevated fecal calprotectin / crp.

2. Your medications

Take these medications exactly as prescribed. Do not stop or change a dose without talking to your provider.

MedicationStarting doseHowWhenWhat it does
mesalamine_oral4-4.8 g PO daily (single dose preferred for adherence)POdailyACG 2025 — first-line for mild-moderate UC; high-dose preferred (≥3 g/day)
mesalamine_rectal1 g PR enema or 1 g suppository dailyPRdailyTopical superior to oral for proctitis; combined topical+oral best for left-sided
sulfasalazine500 mg PO QID titrated to 4 g/dayPOQIDUseful in UC + arthropathy; folate supplementation

Plan: Ulcerative colitis — Truelove-Witts severity-driven induction + advanced therapy maintenance (ACG 2025 + AGA 2024 living + ECCO)

3. Your action plan

Use these zones to know what to do based on how you feel.

GREENIn remission — continue maintenance
If you have:
  • Stable bowel pattern (≤3 BMs/day, formed, no blood)
  • No urgency, tenesmus
  • Normal energy
  • Calprotectin <250 (if measured)
Do this:
  • Take maintenance therapy as prescribed (5-ASA, biologic, immunomodulator)
  • No NSAIDs
  • Keep IBD clinic appointments
  • CRC surveillance per plan
  • Annual labs
YELLOWCaution — early flare, contact IBD team within 24-48 hours
If you have:
  • Increased BMs (>4-5/day)
  • New blood in stool
  • New urgency or tenesmus
  • Mild fatigue or anorexia
  • Mild low-grade fever
Do this:
  • Continue maintenance therapy + add topical 5-ASA (1 g PR daily) if proctitis-prone
  • Hydrate
  • Stool sample for C. diff if available
  • Contact IBD team within 24-48 hours
Call your provider if:
  • Symptoms worsening despite home measures
  • Significant blood in stool
  • New fever
  • Weight loss
REDMedical alert — go to ED now
If you have:
  • ≥6 bloody BMs/day with systemic symptoms (fever >37.8, HR >90, fatigue)
  • Severe abdominal pain or distension
  • Vomiting, rigid abdomen (perforation)
  • Massive hemorrhage
  • Severe lightheadedness
  • Confusion
Do this:
  • Call 911 / go to nearest ED immediately
  • Bring updated medication list
  • Notify IBD team
Call your provider if:
  • Any red zone symptom — ED now, do not wait

4. When to seek emergency care

Call 911 or go to the nearest emergency room right away if you have:

  • ≥6 bloody BMs/day + ≥1 systemic toxicity (T>37.8, HR>90, Hgb<10.5, ESR>30, CRP>30) (ACG 2019)
  • Transverse colon >5.5 cm on AXR + systemic toxicity in active colitis (ACG 2019)(life-threatening)
  • CRP >45 OR ≥8 stools/day OR 3-8 stools + CRP >45 at day 3 of IV steroid (Travis Gut 1996)
  • Positive CMV PCR/biopsy in steroid-refractory ASUC (ACG 2019)
  • Massive lower GI hemorrhage OR free air on imaging (ACG 2019)(life-threatening)

5. Follow-up

Post-induction 8-12w; maintenance q3-6mo stable; flare urgent <1w; ASUC daily inpatient; post-colectomy surgical follow-up; CRC surveillance; preconception counselling

6. Sources

Guideline: 2025 ACG UC Guideline (Rubin) + AGA 2024 Living Guideline (updated 2025) + ECCO 2022 Therapeutics + 2024 EIM update + NICE NG130 (2025-2026) + LUCENT (mirikizumab) + TRUE NORTH (ozanimod) + ELEVATE UC 52/12 (etrasimod) + U-ACHIEVE/U-ACCOMPLISH (upadacitinib) + UNIFI (ustekinumab) + OCTAVE (tofacitinib) + ACT 1/2 (infliximab) + VARSITY

  1. pubmed.ncbi.nlm.nih.gov/28158501
  2. pubmed.ncbi.nlm.nih.gov/31553834
  3. pubmed.ncbi.nlm.nih.gov/34587385